Endoscopic Band Ligation (EBL) Versus Propranolol for Primary Prophylaxis of Variceal Bleeding (NCT00965900) | Clinical Trial Compass
UnknownPhase 4
Endoscopic Band Ligation (EBL) Versus Propranolol for Primary Prophylaxis of Variceal Bleeding
South Korea288 participantsStarted 2006-09
Plain-language summary
This study is performed to compare the efficacy and safety of EBL, propranolol, and EBL combined with propranolol in patients with medium or large varices.
Who can participate
Age range18 Years – 70 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Liver cirrhosis
* Age between 18 and 70 years
* Esophageal varices with high bleeding risk: more than F2 and red color sign
* No previous history of upper gastrointestinal bleeding
* No previous history of endoscopic, radiologic, or surgical therapy for varices or ascites
* Do not take beta-blocker, ACE inhibitor, or nitrate
* Child-Pugh score \<12
Exclusion Criteria:
* Patients with systolic blood pressure \<100 mmHg or basal heart rate \<60/min
* Portal vein thrombosis
* Uncontrolled ascites or hepatic encephalopathy
* Severe coagulation disorder: prothrombin time \<40% (or INR \>1.7) or platelet count \<30,000/mm3
* Medium or large sized gastric or duodenal varices
* Coexisting malignancy
* Severe cardiovascular disorder, renal failure, peritonitis, sepsis
* Severe erosive esophagitis, severe esophageal stricture, active gastric or duodenal ulcer
* Contraindication to beta-blocker
* Pregnancy
* Refusal to give consent to participate in the trial